Core Insights - Trupanion CFO Fawwad Qureshi sold 2,837 shares of common stock for approximately $75,000 as part of a pre-scheduled financial diversification plan [1][9] - This transaction marks the seventh and final sale in a series of consistent transactions since May 2025, all executed under the same trading plan [6][9] Transaction Summary - The shares were sold at a weighted average price of $26.46, slightly below the market close price of $26.54 on February 27, 2026 [2][6] - Post-transaction, Qureshi holds zero common shares directly or indirectly, indicating a complete unwinding of his position [6] Company Overview - Trupanion reported a total revenue of $1.44 billion and a net income of $19.43 million for the trailing twelve months [4] - The company has 1,130 employees and has experienced a 1-year price change of -30.86% [4] Business Model - Trupanion operates a subscription-based model for pet health insurance, generating revenue primarily from premiums paid by pet owners [7][8] - The company emphasizes direct relationships with veterinarians and pet owners, targeting markets in the United States, Canada, Puerto Rico, and Australia [7][8]